Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
115.11B | 111.31B | 113.61B | 108.52B | 100.72B | Gross Profit |
70.37B | 66.82B | 63.56B | 61.70B | 58.81B | EBIT |
26.28B | 20.80B | 15.41B | 13.06B | 12.80B | EBITDA |
50.38B | 44.52B | 43.08B | 38.95B | 38.21B | Net Income Common Stockholders |
11.21B | 17.79B | 8.00B | 6.10B | 6.75B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.37B | 7.24B | 5.62B | 6.01B | 12.94B | Total Assets |
304.93B | 313.44B | 298.59B | 281.63B | 264.92B | Total Debt |
145.15B | 138.75B | 147.75B | 142.07B | 137.26B | Net Debt |
136.78B | 131.52B | 142.14B | 136.06B | 124.32B | Total Liabilities |
206.29B | 222.21B | 211.27B | 200.16B | 192.37B | Stockholders Equity |
63.30B | 56.92B | 48.56B | 42.68B | 35.92B |
Cash Flow | Free Cash Flow | |||
20.70B | 19.43B | 11.71B | 5.81B | 5.05B | Operating Cash Flow |
39.87B | 37.30B | 35.82B | 32.17B | 23.74B | Investing Cash Flow |
-18.90B | -22.91B | -22.31B | -27.40B | -22.65B | Financing Cash Flow |
-20.28B | -12.83B | -15.44B | -10.78B | 7.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €165.86B | 13.60 | 19.60% | 2.68% | 4.90% | 176.57% | |
61 Neutral | $14.35B | 5.84 | -4.31% | 3.69% | 2.75% | -35.67% | |
€3.22B | 18.16 | 2.93% | 0.27% | ― | ― | ||
€3.42B | 14.31 | 18.97% | 6.51% | ― | ― | ||
€5.18B | 11.29 | 7.78% | 6.30% | ― | ― | ||
€106.73M | ― | -291.14% | ― | ― | ― | ||
€4.41B | ― | -1.07% | 1.69% | ― | ― |